Adoptive T Cell Immunotherapy in Melanoma

Dr. Steve Rosenberg, Chief Surgery Branch at National Cancer Institute describes extraordinary clinical outcomes in patients treated with adoptive cellular immunotherapy, using cancer-specific activated T cells.